Long-term irreversible trastuzumab-induced cardiotoxicity for metastatic breast cancer in a patient without cardiac risk factors.
The role of cardiac biomarkers as predictors of trastuzumab cardiotoxicity in patients with breast cancer.
Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment.